Clovis Oncology halts mid-stage bladder cancer trial, shares drop
Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.
from Reuters: Health News https://reut.rs/2GjEKSe
http://bit.ly/2zwRqiM